Healthcare Sales & Marketing Network News: placenta-derived

Searching News Database: placenta-derived

HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2018
Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Nov 2011
Pluristem Announces Positive 12-Month Data From the Use of PLX-PAD for the Treatment of Critical Limb Ischemia
Regenerative Medicine

HSMN NewsFeed - 23 Sep 2009
Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

HSMN NewsFeed - 10 Sep 2009
Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.